Bone Protection

Welcome to the Bone Protection Resource Center! Our goal is to provide current information, news, literature, and other resources in this important area of oncology for you and your patients. If you have any feedback or questions, please contact jadpro-editor@conexiant.com.

David Johnson, PA-C
Director,
Advanced Practice Professional Services
Moffitt Cancer Center

Bone Protection Resource Center

Interview With Saneese Stephen, MPAS, PA-C: Patient Selection for Prevention of Skeletal-Related Events

Targeted Treatments of Bone Metastases in Patients with Lung Cancer

Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology–Cancer Care Ontario Focused Guideline Update

The Advanced Practitioner's Role in Managing Bone Health in Patients With Cancer

Bone Health in Cancer Patients and Survivors

Chemocare: Bone Pain

Lung Cancer

Randomized phase II study of zoledronate dosing every four versus eight weeks in patients with bone metastasis from lung cancer (Hanshin Cancer Group0312)

Current Osteoporosis Reports

Checkpoint inhibitors in bone metastatic disease in solid tumors

Journal of Bone Oncology

Therapeutic approaches in patients with bone metastasis due to endometrial carcinoma – A systematic review

Oncology Nursing News

Bisphosphonates may reduce fracture risk in patients with metastatic hormone-sensitive prostate cancer

Scientific Reports

Long-term use of denosumab and its association with skeletal-related events and osteonecrosis of the jaw

Journal of Bone Oncology

How has the field of metastatic breast cancer in bones evolved over the past 22 years?

Cancer Epidemiology

Low baseline vitamin D levels increase the risk of bone metastases among females with breast cancer − Hospital based cohort study

BMJ Open

Assessment of bone-targeting agents use in patients with bone metastasis from breast, lung or prostate cancer using structured and unstructured electronic health records from a regional UK-based hospital

Oncology Letters

Prognostic assessment of patients who receive radiotherapy for bone metastases from breast cancer

The Oncologist

Bone metastases detection in patients with breast cancer: Does bone scintigraphy add information to PET/CT?

Unknown Primary Cancer Presenting as Osteolytic Bone Lesion

Diagnosis and Management of Bone Metastasis in Stage IV Breast Cancer

Dosing and Duration of BMAs in an Older Patient With Prostate Cancer

Take our brief survey to share how your practice manages bone health

Fast Facts #3: Prostate Cancer and Bone Metastases